Status:
COMPLETED
Ketamine on Acute Pain in Females and Males
Lead Sponsor:
Ullevaal University Hospital
Collaborating Sponsors:
University of Oslo
Conditions:
Mouth and Tooth Diseases
Tooth, Impacted
Eligibility:
All Genders
20-30 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine whether equal subanesthetic doses of racemic ketamine is equally effective on females and males after surgical removal of third molars
Detailed Description
Ketamine is assumed to be a NMDA receptor antagonist which provides analgesia from acute postoperative pain(and other types of pain) subanesthetic doses. Gender differences in ketamine analgesia are n...
Eligibility Criteria
Inclusion
- Indication for removal of third molar
- Between 20 and 30 years of age
- ASA Class 1
Exclusion
- Psychiatric family (father/mother) or own anamnestic history
- Hypersensitivity towards NSAIDS or other rescue analgesics
- Verified or suspected pregnancy
- Lactating females
- Surgery lasting over 60 min
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT00232492
Start Date
January 1 2005
End Date
November 1 2006
Last Update
July 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oral and Maxillofacial Surgery, Ullevaal University Hospital
Oslo, Norway, NO-0407